908 Devices Inc. (NASDAQ:MASS) Analysts Remain Bullish Despite Q2 Earnings Miss

908 Devices Inc.'s Q2 earnings showed statutory losses grew 102% to $0.37 per share and revenues of $13m beat expectations by 7.1%. Analysts have updated their earnings model, forecasting revenues of $55.4m in 2025 and a loss per share of $0.92. The average price target rose 54% to $6.5, indicating that analysts expect the losses to be "one-off" or not have a long-term impact on the business.

908 Devices Inc. (MASS) reported its second-quarter 2025 earnings, revealing a net loss of $0.37 per share, a 102% increase from the previous quarter. Despite the loss, the company's revenue of $13.04 million exceeded analyst expectations by 7.1%, according to the Zacks Consensus Estimate [1].

The company's earnings report comes after a period of restructuring and strategic acquisitions, which have significantly impacted its financial profile. The net loss of $13.3 million in the second quarter is largely attributed to these efforts. However, the company's handheld product and service revenue growth, along with the successful placement of XplorIR and the launch of VipIR, contributed to the overall revenue increase [3].

Analysts have revised their earnings model, forecasting revenues of $55.4 million for 2025, with a loss per share of $0.92. The average price target for 908 Devices Inc. has increased by 54% to $6.5, indicating that analysts expect the losses to be temporary and not have a long-term impact on the business [3].

The company's shares have added about 196.4% since the beginning of the year, outperforming the S&P 500's gain of 7.6%. However, the stock's immediate price movement will depend on management's commentary on the earnings call [1].

While 908 Devices has outperformed the market so far this year, investors are looking ahead to see what's next for the stock. The Zacks Rank #3 (Hold) for the stock indicates that analysts expect the shares to perform in line with the market in the near future. The company's earnings outlook, including current consensus earnings expectations for the coming quarter(s) and the current fiscal year, will be crucial in determining the stock's future performance [1].

Rapid Micro Biosystems, Inc. (RPID), another stock in the same industry, is expected to report its second-quarter results on August 12. The company is expected to post a quarterly loss of $0.26 per share, representing a year-over-year change of +10.3% [1].

In conclusion, 908 Devices Inc.'s Q2 earnings report showed a significant increase in statutory losses, but analysts remain optimistic about the company's future prospects. The company's revenue beat expectations, and analysts have revised their earnings model, forecasting growth in revenues and a temporary loss per share. The stock's performance will depend on management's commentary and the company's ability to execute its strategic initiatives.

References:
[1] https://finance.yahoo.com/news/908-devices-inc-mass-reports-122003516.html
[2] https://simplywall.st/stocks/us/tech/nasdaq-mass/908-devices/news/908-devices-second-quarter-2025-earnings-revenues-beat-expec
[3] https://www.tradingview.com/news/reuters.com,2025:newsml_PLX143DF6:0-chemical-analysis-tools-maker-908-devices-q2-revenue-beats-estimates-raises-fy-forecast/